Patent · US Active

Recombinant baculovirus expression vector and cell

US9909106B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 14, 2014
Grant dateMar 6, 2018
Priority date
Expiry dateMar 13, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/14152
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A recombinant baculovirus expression vector or cell comprising an engineered baculovirus fp25k gene with one to three modified or mutated spots, the modified spots comprise the two 7-adenine mononucleotide repeats (MNR) and the 10th TTAA site. The invention also provides the method of making the vector and baculovirus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.